- AMG 510: How It Targets Cancers With the KRAS G12C Mutation
- EZH2 Inhibitors: How They Work and Their Use in Cancer
- Cdc7 Inhibitor: Targeting Cell Division in Cancer
- Chlorin e6: Uses in Cancer Treatment and Night Vision
- Cetuximab Mechanism of Action: Pathways in Cancer Therapy
- Alvocidib: A Look at This Investigational Cancer Drug
- How Thalidomide Fights Multiple Myeloma Cancer
- Vorinostat’s Mechanism of Action in Cancer Treatment
- Is Cisplatin a Vesicant? Classification and Risks
- What Are EGFR Inhibitors and How Do They Work?
- How Do Pertuzumab and Trastuzumab Work?
- Naxitamab: Immunotherapy for High-Risk Neuroblastoma
- What Is a PKMYT1 Inhibitor and How Does It Work?
- What Is Auristatin and Its Role in Targeted Therapy?
- Lutetium PSMA: A Targeted Cancer Therapy Explained
- Sasanlimab by Pfizer: How the Cancer Treatment Works
- What Are Rapa Therapeutics and How Do They Work?
- What Is a CDK2 Inhibitor and How Does It Work?
- How Octreotide Works to Treat Carcinoid Tumors
- BTK Inhibitors for CLL: How They Work and What to Expect
- Cisplatin Dose: How It’s Determined for Cancer Treatment
- What Is TKI Therapy and How Does It Work?
- PDGFR Inhibitors: How They Work and What They Treat
- Apalutamide vs. Enzalutamide: A Comparison of Treatments
- 5FU Toxicity: Symptoms, Risk Factors, and Treatment
- Nutlin-3: Mechanism of Action and Therapeutic Uses
- What Is a RAF Inhibitor and How Does It Work?
- Topotecan’s Mechanism of Action in Cancer Treatment
- What Is an AKT Inhibitor and How Does It Work?
- What Are Bcl-2 Inhibitors and How Are They Used?